- Home
- NMRA vs FPH Comparison
NMRA vs FPH Comparison
Compare NMRA & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- FPH
- Stock Information
- Founded
- NMRA 2019
- FPH 2009
- Country
- NMRA United States
- FPH United States
- Employees
- NMRA N/A
- FPH N/A
- Industry
- NMRA
- FPH Real Estate
- Sector
- NMRA
- FPH Finance
- Exchange
- NMRA Nasdaq
- FPH Nasdaq
- Market Cap
- NMRA 424.4M
- FPH 390.0M
- IPO Year
- NMRA 2023
- FPH 2017
- Fundamental
- Price
- NMRA $2.20
- FPH $6.31
- Analyst Decision
- NMRA Buy
- FPH
- Analyst Count
- NMRA 8
- FPH 0
- Target Price
- NMRA $7.57
- FPH N/A
- AVG Volume (30 Days)
- NMRA 1.9M
- FPH 181.6K
- Earning Date
- NMRA 11-06-2025
- FPH 10-29-2025
- Dividend Yield
- NMRA N/A
- FPH N/A
- EPS Growth
- NMRA N/A
- FPH 83.55
- EPS
- NMRA N/A
- FPH 1.29
- Revenue
- NMRA N/A
- FPH $193,904,000.00
- Revenue This Year
- NMRA N/A
- FPH N/A
- Revenue Next Year
- NMRA N/A
- FPH N/A
- P/E Ratio
- NMRA N/A
- FPH $4.77
- Revenue Growth
- NMRA N/A
- FPH N/A
- 52 Week Low
- NMRA $0.61
- FPH $3.42
- 52 Week High
- NMRA $11.57
- FPH $6.71
- Technical
- Relative Strength Index (RSI)
- NMRA 41.50
- FPH 60.99
- Support Level
- NMRA $2.55
- FPH $6.09
- Resistance Level
- NMRA $2.78
- FPH $6.47
- Average True Range (ATR)
- NMRA 0.26
- FPH 0.20
- MACD
- NMRA -0.09
- FPH 0.02
- Stochastic Oscillator
- NMRA 10.56
- FPH 77.40
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.